Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?

Abstract Background Pulmonary emphysema combined with systemic sclerosis (SSc)-associated interstitial lung disease (ILD) occurs more often in smokers but also in never-smokers. This study aimed to describe a new finding characterized by peculiar emphysematous change with SSc-associated ILD (SSc-ILD...

Full description

Bibliographic Details
Main Authors: Hideaki Yamakawa, Tamiko Takemura, Tae Iwasawa, Yumie Yamanaka, Satoshi Ikeda, Akimasa Sekine, Hideya Kitamura, Tomohisa Baba, Shinichiro Iso, Koji Okudela, Kazuyoshi Kuwano, Takashi Ogura
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12890-018-0591-y
id doaj-4fdc4878707243aa9fc4bb9ef4d5cabf
record_format Article
spelling doaj-4fdc4878707243aa9fc4bb9ef4d5cabf2020-11-25T02:18:55ZengBMCBMC Pulmonary Medicine1471-24662018-01-011811910.1186/s12890-018-0591-yEmphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?Hideaki Yamakawa0Tamiko Takemura1Tae Iwasawa2Yumie Yamanaka3Satoshi Ikeda4Akimasa Sekine5Hideya Kitamura6Tomohisa Baba7Shinichiro Iso8Koji Okudela9Kazuyoshi Kuwano10Takashi Ogura11Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory CenterDepartment of Pathology, Japanese Red Cross Medical CenterDepartment of Radiology, Kanagawa Cardiovascular and Respiratory CenterDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory CenterDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory CenterDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory CenterDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory CenterDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory CenterDepartment of Radiology, Yokohama Rousai Hospital for Labour Welfare CorporationDepartment of Pathobiology, Yokohama City University Graduate School of MedicineDepartment of Respiratory Medicine, Tokyo Jikei University HospitalDepartment of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory CenterAbstract Background Pulmonary emphysema combined with systemic sclerosis (SSc)-associated interstitial lung disease (ILD) occurs more often in smokers but also in never-smokers. This study aimed to describe a new finding characterized by peculiar emphysematous change with SSc-associated ILD (SSc-ILD). Methods We conducted a retrospective review of 21 consecutive patients with SSc-ILD diagnosed by surgical lung biopsy and focused on the radio-pathological correlation of the emphysematous change. Results Pathological pulmonary emphysema (p-PE) with SSc-ILD was the predominant complication in 16 patients (76.2%) with/without a smoking history, of whom 62.5% were never-smokers. A low attenuation area (LAA) within interstitial abnormality on high-resolution computed tomography (HRCT) was present in 31.3%. Diffusing capacity of the lung for carbon monoxide (DLCO) was lower, disease extent on HRCT higher, and intimal/medial thickening in muscular pulmonary arteries more common in the patients with p-PE with SSc-ILD. However, forced vital capacity (FVC) was well preserved regardless of whether p-PE was observed. Most SSc-ILD patients had pulmonary microvasculature changes in arterioles (90.5%), venules (85.7%), and interlobular veins (81.0%). Conclusions Pulmonary emphysematous changes (LAA within interstitial abnormalities on HRCT and destruction of fibrously thickened alveolar walls) are specific and novel radio-pathological features of SSc-ILD. Peripheral vasculopathy may help to destroy the fibrously thickened alveolar walls, resulting in emphysematous change in SSc-ILD.http://link.springer.com/article/10.1186/s12890-018-0591-ySystemic sclerosisEmphysematous changeVasculopathy
collection DOAJ
language English
format Article
sources DOAJ
author Hideaki Yamakawa
Tamiko Takemura
Tae Iwasawa
Yumie Yamanaka
Satoshi Ikeda
Akimasa Sekine
Hideya Kitamura
Tomohisa Baba
Shinichiro Iso
Koji Okudela
Kazuyoshi Kuwano
Takashi Ogura
spellingShingle Hideaki Yamakawa
Tamiko Takemura
Tae Iwasawa
Yumie Yamanaka
Satoshi Ikeda
Akimasa Sekine
Hideya Kitamura
Tomohisa Baba
Shinichiro Iso
Koji Okudela
Kazuyoshi Kuwano
Takashi Ogura
Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
BMC Pulmonary Medicine
Systemic sclerosis
Emphysematous change
Vasculopathy
author_facet Hideaki Yamakawa
Tamiko Takemura
Tae Iwasawa
Yumie Yamanaka
Satoshi Ikeda
Akimasa Sekine
Hideya Kitamura
Tomohisa Baba
Shinichiro Iso
Koji Okudela
Kazuyoshi Kuwano
Takashi Ogura
author_sort Hideaki Yamakawa
title Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
title_short Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
title_full Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
title_fullStr Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
title_full_unstemmed Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
title_sort emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
publisher BMC
series BMC Pulmonary Medicine
issn 1471-2466
publishDate 2018-01-01
description Abstract Background Pulmonary emphysema combined with systemic sclerosis (SSc)-associated interstitial lung disease (ILD) occurs more often in smokers but also in never-smokers. This study aimed to describe a new finding characterized by peculiar emphysematous change with SSc-associated ILD (SSc-ILD). Methods We conducted a retrospective review of 21 consecutive patients with SSc-ILD diagnosed by surgical lung biopsy and focused on the radio-pathological correlation of the emphysematous change. Results Pathological pulmonary emphysema (p-PE) with SSc-ILD was the predominant complication in 16 patients (76.2%) with/without a smoking history, of whom 62.5% were never-smokers. A low attenuation area (LAA) within interstitial abnormality on high-resolution computed tomography (HRCT) was present in 31.3%. Diffusing capacity of the lung for carbon monoxide (DLCO) was lower, disease extent on HRCT higher, and intimal/medial thickening in muscular pulmonary arteries more common in the patients with p-PE with SSc-ILD. However, forced vital capacity (FVC) was well preserved regardless of whether p-PE was observed. Most SSc-ILD patients had pulmonary microvasculature changes in arterioles (90.5%), venules (85.7%), and interlobular veins (81.0%). Conclusions Pulmonary emphysematous changes (LAA within interstitial abnormalities on HRCT and destruction of fibrously thickened alveolar walls) are specific and novel radio-pathological features of SSc-ILD. Peripheral vasculopathy may help to destroy the fibrously thickened alveolar walls, resulting in emphysematous change in SSc-ILD.
topic Systemic sclerosis
Emphysematous change
Vasculopathy
url http://link.springer.com/article/10.1186/s12890-018-0591-y
work_keys_str_mv AT hideakiyamakawa emphysematouschangewithsclerodermaassociatedinterstitiallungdiseasethepotentialcontributionofvasculopathy
AT tamikotakemura emphysematouschangewithsclerodermaassociatedinterstitiallungdiseasethepotentialcontributionofvasculopathy
AT taeiwasawa emphysematouschangewithsclerodermaassociatedinterstitiallungdiseasethepotentialcontributionofvasculopathy
AT yumieyamanaka emphysematouschangewithsclerodermaassociatedinterstitiallungdiseasethepotentialcontributionofvasculopathy
AT satoshiikeda emphysematouschangewithsclerodermaassociatedinterstitiallungdiseasethepotentialcontributionofvasculopathy
AT akimasasekine emphysematouschangewithsclerodermaassociatedinterstitiallungdiseasethepotentialcontributionofvasculopathy
AT hideyakitamura emphysematouschangewithsclerodermaassociatedinterstitiallungdiseasethepotentialcontributionofvasculopathy
AT tomohisababa emphysematouschangewithsclerodermaassociatedinterstitiallungdiseasethepotentialcontributionofvasculopathy
AT shinichiroiso emphysematouschangewithsclerodermaassociatedinterstitiallungdiseasethepotentialcontributionofvasculopathy
AT kojiokudela emphysematouschangewithsclerodermaassociatedinterstitiallungdiseasethepotentialcontributionofvasculopathy
AT kazuyoshikuwano emphysematouschangewithsclerodermaassociatedinterstitiallungdiseasethepotentialcontributionofvasculopathy
AT takashiogura emphysematouschangewithsclerodermaassociatedinterstitiallungdiseasethepotentialcontributionofvasculopathy
_version_ 1724879899031764992